ArticlePulmonary pharmacology & therapeuticsPublished
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Pulmonary pharmacology & therapeutics
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Acetamides; Pyrazines; Antihypertensive Agents; Administration, Oral; Dose-Response Relationship, Drug; United States; Pulmonary Arterial Hypertension; Recommendations; Guidelines; Best Practice; Selexipag
- PubMed ID
- 41519430
- Added to directory
- Source checked